A look at the recent approval of Eli Lilly and Incyte's Olumiant (baricitinib) and potential use in alopecia areata

Executed on:Jun 17, 2022 2:45 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: Henry Ford Health

Board-certified dermatologist and fellowship-trained dermatologist
Faculty at Henry Ford Dept. of Dermatology.
 Authored several peer reviewed publications and has written multiple textbook chapters and served as an investigator on 40 clinical trials.
Research interest includes aser and cosmetic procedures & vein treatment and sclerotherapy.
Manages 300 patients with Alopecia Areata and prescribes olumiant to 10 patients.

Interview Goal

This conversation will focus on discussing the recent FDA Approval of Oluminant in treating patients with alopecia areata

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.